UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib

Circulation (New York, N.Y.), 2001-11, Vol.104 (19), p.2280-2288

2001

Volltextzugriff (PDF)

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet

Clinical pharmacology and therapeutics, 2002-07, Vol.72 (1), p.50-61

2002

Volltextzugriff (PDF)

Results of a randomized, dose‐ranging trial of etoricoxib in patients with osteoarthritis

British journal of rheumatology, 2002-09, Vol.41 (9), p.1052-1061

2002

Volltextzugriff (PDF)

Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone Alone

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1759-1767

2001

Volltextzugriff (PDF)

Pharmacokinetics of alendronate

Clinical pharmacokinetics, 1999-05, Vol.36 (5), p.315-328

1999

Volltextzugriff (PDF)

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial

Annals of internal medicine, 2000-07, Vol.133 (1), p.1

2000

Volltextzugriff (PDF)

Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX-2 versus COX-1 in Healthy Volunteers

Journal of clinical pharmacology, 2000-10, Vol.40 (10), p.1109-1120

2000

Volltextzugriff (PDF)

A CGE Framework for Modeling the Economics of Flooding and Recovery in a Major Urban Area

Risk analysis, 2019-06, Vol.39 (6), p.1314-1341

2019

Volltextzugriff (PDF)

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

European journal of cancer (1990), 2001-05, Vol.37 (7), p.835-842

2001

Volltextzugriff (PDF)

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

Clinical pharmacology and therapeutics, 1999-03, Vol.65 (3), p.336-347

1999

Volltextzugriff (PDF)

Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis

Annals of the rheumatic diseases, 2004-07, Vol.63 (7), p.857-861

2004

Volltextzugriff (PDF)

Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids

The Journal of pharmacology and experimental therapeutics, 1999-05, Vol.289 (2), p.735

1999

Volltextzugriff (PDF)

Diffusion Tensor Imaging Detects Areas of Abnormal White Matter Microstructure in Patients with Partial Ornithine Transcarbamylase Deficiency

American journal of neuroradiology : AJNR, 2010-10, Vol.31 (9), p.1719-1723

2010

Volltextzugriff (PDF)

Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women

The journal of clinical endocrinology and metabolism, 2001-03, Vol.86 (3), p.1116-1125

2001

Volltextzugriff (PDF)

Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis

Journal of bone and mineral research, 1997-10, Vol.12 (10), p.1700-1707

1997

Volltextzugriff (PDF)

A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis

Alimentary pharmacology & therapeutics, 2002-03, Vol.16 (3), p.415-423

2002

Volltextzugriff (PDF)

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

The New England journal of medicine, 1999-01, Vol.340 (3), p.190-195

1999

Volltextzugriff (PDF)

Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans

European journal of clinical pharmacology, 2000-05, Vol.56 (2), p.167-174

2000

Volltextzugriff (PDF)

Studies of the oral bioavailability of alendronate

Clinical pharmacology and therapeutics, 1995-09, Vol.58 (3), p.288-298

1995

Volltextzugriff (PDF)

Dose-response relationships for alendronate treatment in osteoporotic elderly women

The journal of clinical endocrinology and metabolism, 1997, Vol.82 (1), p.265-274

1997

Volltextzugriff (PDF)

Monitoring bone resorption in early postmenopausal women by an immunoassay for cross‐linked collagen peptides in urine

Journal of bone and mineral research, 1994-02, Vol.9 (2), p.135-142

1994

Volltextzugriff (PDF)

Concurrent Administration of the Erythromycin Breath Test (EBT) and Oral Midazolam as In Vivo Probes for CYP3A Activity

Journal of clinical pharmacology, 1999-12, Vol.39 (12), p.1212-1220

1999

Volltextzugriff (PDF)

Renal Effects of COX-2-Selective Inhibitors

American journal of nephrology, 2001-01, Vol.21 (1), p.1-15

2001

Volltextzugriff (PDF)

MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism

The journal of clinical endocrinology and metabolism, 1998-02, Vol.83 (2), p.320-325

1998

Volltextzugriff (PDF)

Epoetin theta: efficacy and safety of IV administration in anaemic haemodialysis patients in the maintenance phase in comparison to epoetin beta

Current medical research and opinion, 2010-10, Vol.26 (10), p.2393-2402

2010

Volltextzugriff (PDF)

1 – 25 von 817

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(753)
Mit Volltextzugriff
(685)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(789)
Deutsch
(24)
Dänisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet

Results of a randomized, dose‐ranging trial of etoricoxib in patients with osteoarthritis

Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone Alone

Pharmacokinetics of alendronate

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial

Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX-2 versus COX-1 in Healthy Volunteers

A CGE Framework for Modeling the Economics of Flooding and Recovery in a Major Urban Area

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis

Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids

Diffusion Tensor Imaging Detects Areas of Abnormal White Matter Microstructure in Patients with Partial Ornithine Transcarbamylase Deficiency

Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women

Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis

A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis

Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor Antagonist

Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans

Studies of the oral bioavailability of alendronate

Dose-response relationships for alendronate treatment in osteoporotic elderly women

Monitoring bone resorption in early postmenopausal women by an immunoassay for cross‐linked collagen peptides in urine

Concurrent Administration of the Erythromycin Breath Test (EBT) and Oral Midazolam as In Vivo Probes for CYP3A Activity

Renal Effects of COX-2-Selective Inhibitors

MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism

Epoetin theta: efficacy and safety of IV administration in anaemic haemodialysis patients in the maintenance phase in comparison to epoetin beta

Suchergebnisse filtern